Affiliation:
1. Division of Infectious Diseases, Departments of Medicine and Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York 10032
Abstract
The in vitro activity of mecillinam, a 6 β-amidinopenicillanic acid derivative, was investigated. Mecillinam is not active against most gram-positive coccal or bacilliary forms. Many members of the
Enterobacteriaceae
are inhibited, with 86% of
Escherichia coli
, 71% of Klebsiella, 62% of
Enterobacter
, 75% of
Salmonella
, 69% of
Shigella
, and 70% of
Citrobacter
inhibited by 6.3 μg/ml. Indole-positive
Proteus
and
Serratia
were generally resistant as are
Pseudomonas
strains. Although mecillinam is hydrolyzed by gram-negative β-lactamases, the compound inhibits β-lactamase-producing organisms, particularly
E. coli
. The conductivity of medium used to determine minimal inhibitory concentration and inoculum size produce markedly different values. In medium of high conductivity, 10 mS, mecillinam is inactive against many strains of bacteria. In all media there is a great difference between the minimal inhibitory and minimal bactericidal levels.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
86 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献